The Mastocytosis Control Test: A Patient-Reported Outcome Measure Assessing Disease Control
The MCT is a disease-specific, valid, and reliable PROM for adult patients with nonadvanced disease. It may measure and monitor disease control in routine daily practice and clinical trials.
Authors
- Shazia Sofi
- Frank Siebenhaar (ORCID: https://orcid.org/0000-0003-4532-1644)
- Sophia Neisinger (ORCID: https://orcid.org/0009-0000-5967-4809)
- Lea Kiefer (ORCID: https://orcid.org/0000-0003-2882-4784)
- Martin Metz (ORCID: https://orcid.org/0000-0002-4070-9976)
- Cem Akin (ORCID: https://orcid.org/0000-0001-6301-4520)
- Markus Magerl (ORCID: https://orcid.org/0000-0001-9218-5468)
- Polina Pyatilova (ORCID: https://orcid.org/0000-0001-5520-2900)
- Tomasz Hawro (ORCID: https://orcid.org/0000-0001-9990-1332)
- Karsten Weller (ORCID: https://orcid.org/0000-0003-4437-0313)
- Eva Grekowitz (ORCID: https://orcid.org/0000-0002-7356-7126)
- Marcus Maurer (ORCID: https://orcid.org/0000-0002-4121-481X)
- Antje Haendel
Institutions
- University of Michigan (US)
- Humboldt-Universität zu Berlin (DE)
- National Patient Safety Foundation (US)
Publication Details
- Journal
- The Journal of Allergy and Clinical Immunology In Practice
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1016/j.jaip.2024.11.021
- Citations
- 4
- Primary Topic
- Mast cells and histamine
- Type
- article
- Field-Weighted Citation Impact
- 0.96
Funders
- Charité – Universitätsmedizin Berlin